$TR

GSA Capital Partners LLP Has $703,000 Stock Position in Tootsie Roll Industries, Inc. $TR

GSA Capital Partners LLP reduced its stake in Tootsie Roll Industries (NYSE:TR) by 60.9% in the third quarter, now holding 16,761 shares valued at $703,000. Other institutional investors like NBT Bank N A NY and CWM LLC have recently adjusted their positions in the company. Tootsie Roll Industries stock opened at $41.46, has a market cap of $3.03 billion, and recently announced a quarterly dividend of $0.09 per share with an ex-dividend date of March 5th.

Original reporting
MarketBeat · MarketBeat
Published Feb 22, 2026, 10:26 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Feb 22, 2026, 10:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
GSA Capital Partners LLP Has $703,000 Stock Position in Tootsie Roll Industries, Inc. $TR — source image
Decision brief

The 30-second read

$TRNeutralLow
01

Why it matters

While the stake reduction is notable, the stock's stable opening and dividend announcement suggest limited immediate impact. The overall effect on stock price is uncertain without additional data.

02

Market read

The news indicates a notable institutional stake change but has limited immediate trading implications for the broader market.

03

What to watch

Broader market conditions, company fundamentals, and technical indicators are not provided, limiting comprehensive analysis.

Relevance 6/10Timing: short-term

Background

GSA Capital Partners LLP reduced its stake significantly in Tootsie Roll Industries, which could reflect changing institutional sentiment.

Company-level read

Ticker impact

$TRNeutralMedium confidence
Context

High relevance due to recent institutional activity and dividend announcement.

Expected impact

Minimal short-term price movement expected; potential slight decline if institutional selling continues.

Evidence & confidence

The significant stake reduction (60.9%) by a major investor could signal a shift in sentiment, but the stock's stable opening and dividend news suggest limited immediate impact. Technical indicators and broader market conditions are not provided, limiting prediction accuracy.

Market effects

Limited; the news primarily affects institutional investor behavior in the consumer staples sector.

Minimal; no regional effects indicated.

Low; the news is specific to a single company's institutional activity.

Counterpoint

The reduction in institutional stake may be a temporary repositioning rather than a negative outlook.

Key entities

  • GSA Capital Partners LLP

    A hedge fund that reduced its stake in Tootsie Roll Industries.

  • Tootsie Roll Industries, Inc.

    A manufacturer of confectionery products, traded under ticker TR.

Related articles

$TRHigh

TOOTSIE ROLL INDUSTRIES INC (TR): Results of Operations and Financial Condition

TOOTSIE ROLL INDUSTRIES INC (TR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ​ ​ TOOTSIE ROLL INDUSTRIES, INC. ​ ​ 7401 South Cicero Avenue ​ Chicago, IL 60629 ​ Phone 773/838-3400 ​ Fax 773/838-3534 ​ PRESS RELEASE ​ ​ ​ ​ ​ STOCK TRADED: NYSE FOR IMMEDIATE RELEASE TICKER SYMBOL: TR Wednesday, October 21, 2026 ​ ​ ​ CHICAGO, ILLINOIS – Octob

$TRMedAI 9/10

Técnicas Reunidas awarded EPCM contract for Coastal GasLink project

Técnicas Reunidas' subsidiary, TR Canada E&C, won a €200M+ contract for EPCM services on Phase 2 of the Coastal GasLink project in British Columbia. The project, owned by LNG Canada (a joint venture including Shell, Petronas, PetroChina, Mitsubishi, and KOGAS), involves building compressor stations and modifying facilities. The contract is expected to last over four years.

$TRMed

TOOTSIE ROLL INDUSTRIES INC (TR): Results of Operations and Financial Condition

TOOTSIE ROLL INDUSTRIES INC (TR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tr-20260722xex99d1.htm EX-99.1 Exhibit 99.1 ​ ​ TOOTSIE ROLL INDUSTRIES, INC. ​ ​ 7401 South Cicero Avenue ​ Chicago, IL 60629 ​ Phone 773/838-3400 ​ Fax 773/838-3534 ​ PRESS RELEASE ​ ​ ​ ​ ​ STOCK TRADED: NYSE FOR IMMEDIATE RELEASE TICKER SYMBOL: TR Wednesday, July 22

$UTHRMed

United Therapeutics Gets FDA Clearance To Begin Trial Of Inhaled PAH Therapy

United Therapeutics (UTHR) received FDA clearance to start clinical trials for Treprostinil-Iloprost SMI, an inhaled therapy for pulmonary arterial hypertension (PAH). The Phase 1 trial will assess safety and pharmacokinetics in healthy volunteers. If successful, a Phase 2 trial in PAH patients is planned for 2027. UTHR stock closed at $591.20, down 0.28%.